3 Distinct businesses
Injectables. We supply hospitals across our markets with generic injectable products, supported by our manufacturing facilities in the US, Europe and MENA
Branded. We supply branded generics and in-licensed patented products from our local manufacturing facilities to retail and hospital customers across the MENA region
Generics. We supply oral and other non‑injectable generic and specialty products to the US retail market, leveraging our state-of-theart manufacturing facility in Columbus, Ohio
In the US, Hikma 503B provides outsourced sterile compounding services for injectables medicines. Discover more about 503B
760+
Products on the market
32
Manufacturing plants
8
R&D centers worldwide
Related news
Hikma launches Cefazolin for Injection, USP, in the US
20 March 2023
Last reviewed on 30 May 2022